| The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases MR Zinatizadeh, B Schock, GM Chalbatani, PK Zarandi, SA Jalali, SR Miri Genes & diseases 8 (3), 287-297, 2021 | 261 | 2021 |
| Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB/c mice H Ghaffari-Nazari, J Tavakkol-Afshari, MR Jaafari, ... PloS one 10 (11), e0142563, 2015 | 131 | 2015 |
| Bypassing protein corona issue on active targeting: zwitterionic coatings dictate specific interactions of targeting moieties and cell receptors R Safavi-Sohi, S Maghari, M Raoufi, SA Jalali, MJ Hajipour, ... ACS applied materials & interfaces 8 (35), 22808-22818, 2016 | 103 | 2016 |
| Isolation of adipose tissue mesenchymal stem cells without tissue destruction: a non-enzymatic method A Ghorbani, SA Jalali, M Varedi Tissue and Cell 46 (1), 54-58, 2014 | 97 | 2014 |
| P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer S Shariat, A Badiee, SA Jalali, M Mansourian, M Yazdani, SA Mortazavi, ... Cancer letters 355 (1), 54-60, 2014 | 73 | 2014 |
| Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN M Mansourian, A Badiee, SA Jalali, S Shariat, M Yazdani, M Amin, ... Immunology letters 162 (1), 87-93, 2014 | 68 | 2014 |
| Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles SA Jalali, M Sankian, J Tavakkol-Afshari, MR Jaafari Nanomedicine: Nanotechnology, Biology and Medicine 8 (5), 692-701, 2012 | 67 | 2012 |
| Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis VH Shargh, MR Jaafari, A Khamesipour, I Jaafari, SA Jalali, A Abbasi, ... Vaccine 30 (26), 3957-3964, 2012 | 61 | 2012 |
| CAR-T cells: Early successes in blood cancer and challenges in solid tumors H Dana, GM Chalbatani, SA Jalali, HR Mirzaei, SA Grupp, ER Suarez, ... Acta Pharmaceutica Sinica B 11 (5), 1129-1147, 2021 | 56 | 2021 |
| Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies AR Nikpoor, J Tavakkol-Afshari, K Sadri, SA Jalali, MR Jaafari Nanomedicine: Nanotechnology, Biology and Medicine 13 (8), 2671-2682, 2017 | 56 | 2017 |
| A new world of biomarkers and therapeutics for female reproductive system and breast cancers: circular RNAs AM Tran, GM Chalbatani, L Berland, M Cruz De los Santos, P Raj, ... Frontiers in cell and developmental biology 8, 50, 2020 | 51 | 2020 |
| Bare surface of gold nanoparticle induces inflammation through unfolding of plasma fibrinogen B Kharazian, SE Lohse, F Ghasemi, M Raoufi, AA Saei, F Hashemi, ... Scientific reports 8 (1), 12557, 2018 | 48 | 2018 |
| Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis V Heravi Shargh, MR Jaafari, A Khamesipour, SA Jalali, H Firouzmand, ... Parasitology research 111, 105-114, 2012 | 48 | 2012 |
| Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model. JMR Nikpoor AR, Tavakkol-Afshari J, Gholizadeh Z, Sadri K, Babaei MH ... Int J Pharm 495 (1), 162–170, 2015 | 47 | 2015 |
| Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis Z Amirghofran, SA Jalali, SV Hosseini, M Vasei, B Sabayan, A Ghaderi Journal of gastrointestinal cancer 39, 73-78, 2008 | 43 | 2008 |
| Two virus-induced MicroRNAs known only from teleost fishes are orthologues of MicroRNAs involved in cell cycle control in humans BD Schyth, DB Bela-Ong, SAH Jalali, LBJ Kristensen, K Einer-Jensen, ... PLoS One 10 (7), e0132434, 2015 | 41 | 2015 |
| Poly (I: C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model GA Talesh, Z Ebrahimi, A Badiee, M Mansourian, H Attar, L Arabi, ... Immunology letters 176, 57-64, 2016 | 35 | 2016 |
| Genetic polymorphism in the transforming growth factor β1 gene (-509 C/T and-800 G/A) and colorectal cancer Z Amirghofran, SA Jalali, A Ghaderi, SV Hosseini Cancer genetics and cytogenetics 190 (1), 21-25, 2009 | 32 | 2009 |
| P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer N Farzad, N Barati, AA Momtazi-Borojeni, M Yazdani, A Arab, A Razazan, ... Artificial cells, nanomedicine, and biotechnology 47 (1), 664-672, 2019 | 30 | 2019 |
| Synergistic antitumor effect of anti‐PD‐L1 combined with oxaliplatin on a mouse tumor model S Golchin, R Alimohammadi, M Rostami Nejad, SA Jalali Journal of cellular physiology 234 (11), 19866-19874, 2019 | 27 | 2019 |
Ali BadieeSchool of Pharmacy, Mashhad University of Medical Sciencesmums.ac.ir üzerinde doğrulanmış e-posta adresine sahip
